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No. Fatty C 18: 1 C 18:2 C 20:4 Fatty C 18: 1 C 18:2 C 20:4
Acids Acids
0/9 % % ~~~~~~~~~~~0/9 09 / %%%
Slowing* Slowing* Inhibiriont Slon Inhibitiont Slowmg* Inhibitiont Slowing* Slowing' Inbibitiont Slowing Inhibitiont Slowing* Inhibitiont
| (a) (b) | _ _ (b) (b) (a) (b) (b) _ (b) _
Normal Subjects
1 18-3 17-8 2-7 7*1 61-2 - - _ _ - _ - _ -
2 17-5 16-0 8-6 6-3 64 0 3-4 82-0 - _ _ _ _ _ -
3 17 6 16-6 5 7 6 6 62-5 3-8 78 4 - - - - - - -
4 18-2 17-5 3-8 7*2 60-4 3-6 80-2 19-6 18-7 4-6 8*5 57 0 4-5 72-0
di 17-4 17-2 1-2 6-6 62-1 3-7 78-8 - - - - - - -
6 17-5 17-0 2-7 6-9 60-5 4-2 76:0 19-5 18-6 4-6 8-8 54-9 4-5 76-97 18-1 17-8 1-7 7-2 61-2 3-6 80-1 19-8 19*6 1.0 97 50 0 6-6 67-0
8 18-3 18*2 0 5 7 0 61-7 3-8 79-2 - - - - -_ -
M.S. Patients
9 17-7 17-5 1 1 2-9 84-0 0 9 95 0 1 - _
10 14-1 13-8 2-1 1-8 87-2 0-8 94.3 - - - - - - -
11 11-2 11.0 1-8 1-3 884 0-3 97.3 - - - - - - -
Reduction of macrophage mobility brought about by lymphocyte-antigen reaction.
tPercentage change in macrophage slowings calculated: a x 100.
TABLE I.-Inhibition of the Encephalitogenic-Factor-induced Lymphocyte Response by Fatty Acids in M.S. Patients and Patients with Other Neurological Diseases
Measured With the Macrophage Electrophoretic Mobility test.
No Fatty C 18:1 C 18:2 C 20:4
Case No. Acids
Slowing Slowing* Inhibitiont Slowing* Inhibitiont Slowing* Inhibitiont
(a) (b) (b) (b)
Multiple Sclerosis
9 18-4 17-9 2-7 1-9 87-7 1-2 93*5
10 14-7 144 2-0 1-8 87-7 0-6 96-0
11 14-8 14-3 3-4 1-8 87-8 0-8 94-6
Other Neurological Diseases
12 17-2 16-6 3-5 9.4 45-4 5-4 68-6
13 14-7 14-5 1-4 7-7 47-6 4-5 69-4
14 18-3 17-9 2-2 9-8 46-4 5-6 69-4
*Reduction of macrophage mobility brought about by lymIhocyte-antigen reaction.
tPercentage change in macrophage slowings calculated: x 100.
improemrent in clinical course in a group of
patients treated over a two-year period.
Several investigations have revealed signifi-
cant alterations in the fatty acid. composition
of brain lipidsl 2 and of the serum3' M.S., so
that the effect of such a diet might be re-
garded as an attempt at substitution therapy.
However, the results of Turnell et al.5 indicate
that free fatty acids may play an important
part in the immunosuppressive effect of
corticosteroids, and so it seemed possible
that the increase of the linoleate serum level
might have an immunosuppressive effect in
these patients.
To test this hypothesis we studied the
effects of oleic acid (C 18:1), linoleic acid
(C 18:2), and arachidonic acid (C 20:4) on
the human lymphocyte response to three
antigens-purified protein derivative of tub-
erculin (P.P.D.), encephaliftogenic factor, and
thyroid antigen (F1 + F,), using the macro-
phage electrophoretic mobility test.67 In this
test the percentage slowing of norml guinea-
pig macrophages in an electric field measures
lymphocyte-antigen interaction. It is these
percentages which are shown in tables 1
and II. Lymphocytes from normal subjects
as well as from patients with M.S. and other
neurological diseases were studied.
With a dosage of fatty acid of 0-08 mg/ml
(corresponding to the normnal serum level of
unesterified oleic and twice the normal level
of unesterified linoleic acid) we found a sig-
nificant inhibition caused by both linoleic
and arachidonic acid, whereas oleic acid was
virtually without effect. The inhibition
occurred only when the fatty acids were
added to the lymphocytes before the antigen.
When antigen was allowed to interact with
the lymphocytes for 1-5 min and linoleic
acid was then added no inhibition was to be
observed, suggesting that the acid may in-
hibit the recognition of antigen by the
lymphocytes. The interference with lympho-
cyte-antigen interaction by linoleic and
arachidonic acid occurred not only with
P.P.D. and thyroid as antigens in normal
subjects (table I) but equally with P.P.D.
and encephalitogenic factor in M.S. patients
and those with other neurological diseases
(tables I and II). The percentage inhibition
was higher in M.S. patients than in the
control groups.
In the context of M.S. the present results
may offer an explanation for the findings
by Dr. Millar and his colleagues of the
beneficial effect of linoleic acid treatment.
Such treatment might be expected to reduce
lymphocyte attack upon brain antigen in situ
and (if such an autoaggressive process is
indeed at the root of M.S. pathogenesis) so
hold up the progress of the disease.
Furrher studies of the possible immuno-
regulatory effect of unsaturated fatty acids
(dependent perhaps on chain length and
degree of unsaturation) in normal subjects, in
M.S., and in the wider field of clinical
immunology are indicated.
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Fibrinolysis in Cholestatic Jaundice
SIR,-The paper by Dr. A. Jedrychowsi and
his colleagues (17 March, p. 640) reporting
decreased fibrinolytic activity in patients with
cholestatic jaundice prompts us to report the
preliminary results of a similar study.
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Patients Normal Values
Test Mean ± S.D. Mean + S.D.
Euglobulin lysis time (units/ml) 2-7 + 1.1* 12-0 ± 5-3
Plasminogen (units/100 ml) .99 ± 22 100 ± 21
Fibrinogen (mg/100 ml) .636 ± 192* 350 ± 84
Factor VIII (%) .. 218 + 66* 104 ± 23
Antithrombin III (%) .108 ± 26 100 + 10
Thrombin time (sec) .18-0 + 3-2t 15-0 + 0 4
Reptilase time (sec) 18-1 + 1-8t 15-8 ± 0 9
Normotest (%) .. 90± 18 94 ± 16
Thrombotest (%).39 + 27* 90 ± 15
P< 0-001 tP< 0-02
Our findings in 11 patients with large bile
duct obstruction of varying aetiology pre-
treated with vitamin K before testing are
shown in the table. There was a pronounced
decrease of plasminogen activator without
variations in the plasminogen concentration.
Fibrinogen and factor VIII levels were very
high; progressive antithrombin (antithrombin
III) assayed immunochemically was normal;
and the thrombin and Reptilase times, which
relate to the last phase of blood coagulation,
were significantly prolonged. Normotest and
Thrombotest are standardized coagulation
tests sensitive to variations in the plasma
levels of factors II, VII, and X. In our
patients the Thrombotest, which is known
to be influenced by coagulation inhibitors,
was low, whereas the Normotest, which is
affected only by the clotting factor conoen-
trations, gave normal results in the same
plasma samples.
The findings of an abnormal Thrombotest
and thrombin and Reptilase times suggest
the presence in these patients of some degree
of inhibition of the clotting mechanisms in-
dependent of vitamin K deficiency. We are
now trying to discover whether the inhibitory
activity may be related to the high levels of
bilirubin glycuronides, as suggested by the
experimental findings of Kopec et al.1 There-
fore, while confirmiing the finding by Dr.
Jedrychowski and his colleagues and other
authors24 of decreased fiibrinolysis and high
levels of clotting factors in these patients,
our results show that other coagulation ab-
normalities are present in addition to the
well-known vitamin K-dependent deficiency
of clotting factors.
Dr. Jdrychowski and his colleagues suggest
that decreased fibrinolysis may render these
patients particularly liable to postoperative
venous thrombosis. This view is not sup-
ported by the available evidence, which
shows that the incidence of deep vein throm-
bosis after biliary surgery is no higher than
after surgical operations of comparable
severity.5-7 In our experience, bleeding is a
greater problem than tdromboemlbolism in
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Simple Finger Tourniquet
SIR,-While working recently as a casualty
registrar I had to perform many minor op-
erations on fingers and toes, many of them
under ring anaesthesia and some under gen-
eral anaesthesia. I found that rubber tube
finger tourniquets nearly always snapped
when the tension was increased beyond the
point of obstruction of venous flow, or
caused more bleeding if they stayed intact.
A simple alternative method of ex-
sanguinating the digit and a,pplying a good
working tourniquet which I devised is to
cut off the finger of a disposable glove, cut
off its tip as well, stretch and apply it to the
finger or toe to be operated on, and roll it
proximally to form a ring at the base of the
digit. This provides a satisfactory bloodless
field for any operation and the ring can be
readily cut for removal after surgery.-I am,
etc.,
MOHJAM ZAKI ALI SALEM
George Eliot Hospital
Nuneaton.
Australia Antigen in VD. Clinic Patients
SIR,-Dr. D. J. Jeffries and others (26 May,
p. 455) claim to show a difference between
the numbers of Australia-antigen-positive
patients among those attending a venereal
disease clinic and the numbers of Australia-
antigen-positive individuals among blood
donors.
Blood donors are not a useful group for
comparison in this case as they are not repre-
sentative of the general population. At each
attendance potential donors, before being
accepted, are asked both if they have ever
had jaundice and if they have recently been
in contact with a case of jaundice. No such
screening method is applied to potential
patients at venereal disease clinics.
This observation in no way affects the
differences that were found between groups




Is Your Pain Really Necessary?
SIR,-I was interested in your comments
(leading article, 12 May, p. 323) on the
aetiology of infantile colic. This common
disorder causes much distress to both mother
and infant and many visits to the family
doctor, who may well be rather baffled by
it. Certainly I agree that the theory of the
colic being a result of maternal anxiety
rather parallels the chicken-egg controversy.
What mother would not be anxious when her
infant continuously screams, sleeps for only
brief periods, and feeds poorly? The
occurrence of these symptoms, together with
the predis,position to vomiting and/or
diarrhoea, which may be difficult to treat, is
sometimes due to cow's milk intolerance.
With a history of this disorder and its very
difficult weaning period when the infant is
first exposed to cow's milk products, the
possibility of the two occurrences being re-
lated should be borne in mind. The addi-
tional presence of flexural eczema would be
a certain indication to withdraw cow's milk
products for a trial period of three to four
weeks and replace them with a synthetic
mil,k substitute such as Nutramigen.
I would add that the term "milk intoler-
ance" is used deliberately and the term
"allergy" avoided since there is seldom a
true atopic status, and specific circulating or
cell-fixed antibodies are not demonstrable;
indeed the lesion may be at the level of the
intestinal villus, as in lactase deficiency.
Many patients with milk intolerance will
grow out of their trouble and be able to
tolerate milk products in later childhood,
often by the fifth or sixth year.
I have often observed children of school
age who are of rather small stature, often
with obstinate eczema, and frequently with
a history of unexplained and various gastro-
intestinal difficulties extending back to their
first year of life, when they were described
as "colicky." These children have responded
to withdrawal of ingested cow's milk by
the losing of their eczema, stopping their
gastrointestinal symptoms, and gaining weight
and height with gratifying speed. Serum
IgE and IgA levels are usually normal, and
the skin tests to milk negative. The sub-
stitute of cows milk by goat's milk is quite
useless in this condition and the only correct






Cardiological Changes and Car Driving
SIR,-The results reported by Dr. W. A.
Littler and others (5 May, p. 273) are
interesting but one wonders how valid t-hey
are.
A clinical assumption (and indeed a lay
one) is that prolonged driving in heavy
traffic or on motorwrays can provide a cardiac
stress. Very many salesmen and manarers
drive long distances several tiimes a week to
attend to often stressful business affairs,
after which they drive ho<ne or to another
business meeting. To drive for up to 60
minutes two or three times a day is quite a
d;fferent matter from driving for three hours,
working for seven and driving again for
another three. Fatigue in itself is a stress, and
this plus the effect of either a pounding
motorway journev or a trans-London or
trans-West Midlands drive would, I believe,
if measured, provde auite different fiaures
from those obtained bv Dr. Littler and his
coll'aptues. One excludes Professional truck
drivers since thev are self-selected and do
not fall into the same category as those who
perforce have to drive lono distances on top
of their normal work; 30.000 miles a year
is not uncommon for young manacers.
In cases of ischaemic heart disease in
youneer patients I am now in the habit of
taking a driving history, and my impression
